nach oben

Journal of Cardiovascular Translational Research

Erschienen in:

01.06.2010

MicroRNAs in Cardiovascular Diseases: Biology and Potential Clinical Applications

verfasst von: Reena V. Kartha, Subbaya Subramanian

Erschienen in: Journal of Cardiovascular Translational Research | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Cardiovascular diseases represent one of the major causes for increasing rates of human morbidity and mortality across the world. This reinforces the necessity for the development of novel diagnostics and therapies for the early identification and cure of heart diseases. MicroRNAs are evolutionarily conserved small regulatory non-coding RNAs that regulate the expression of large number of genes. They are involved in several cellular pathophysiological pathways and have been shown to play a significant role in the pathogenesis of many disease states. Recent studies have correlated dysregulated miRNA expressions to diseased hearts and also shown the relevance of miRNA in growth, development, function, and stress responsiveness of the heart. The possibility of exploiting miRNAs to develop diagnostic markers or manipulating them to obtain therapeutic effects is very attractive since they have very specific targets in a particular cellular pathway. In this review we will summarize the role played by miRNAs in the heart and discuss the scope of utilizing miRNA-based strategies in the clinics for the benefit of mankind.

Abbas, N. A., John, R. I., Webb, M. C., Kempson, M. E., Potter, A. N., Price, C. P., et al. (2005). Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clinical Chemistry, 51, 2059–2066.PubMedCrossRef

Ai, J., Zhang, R., Li, Y., Pu, J., Lu, Y., Jiao, J., et al. (2010). Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochemical and Biophysical Research Communications, 391, 73–77.

Altuvia, Y., Landgraf, P., Lithwick, G., Elefant, N., Pfeffer, S., Aravin, A., et al. (2005). Clustering and conservation patterns of human microRNAs. Nucleic Acids Research, 33, 2697–2706.PubMedCrossRef

Asangani, I. A., Rasheed, S. A., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., et al. (2008). MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27, 2128–2136.PubMedCrossRef

Barringhaus, K. G., & Zamore, P. D. (2009). MicroRNAs: Regulating a change of heart. Circulation, 119, 2217–2224.PubMedCrossRef

Bartel, D. P. (2009). MicroRNAs: Target recognition and regulatory functions. Cell, 136, 215–233.PubMedCrossRef

Beltrami, A. P., Urbanek, K., Kajstura, J., Yan, S. M., Finato, N., Bussani, R., et al. (2001). Evidence that human cardiac myocytes divide after myocardial infarction. New England Journal of Medicine, 344, 1750–1757.PubMedCrossRef

Bernstein, E., Kim, S. Y., Carmell, M. A., Murchison, E. P., Alcorn, H., Li, M. Z., et al. (2003). Dicer is essential for mouse development. Nature Genetics, 35, 215–217.PubMedCrossRef

Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., et al. (2009). MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science, 324, 1710–1713.PubMedCrossRef

10.

Borchert, G. M., Lanier, W., & Davidson, B. L. (2006). RNA polymerase III transcribes human microRNAs. Nature Structural & Molecular Biology, 13, 1097–1101.CrossRef

11.

Calin, G. A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S. E., et al. (2005). A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. New England Journal of Medicine, 353, 1793–1801.PubMedCrossRef

12.

Callis, T. E., Pandya, K., Seok, H. Y., Tang, R. H., Tatsuguchi, M., Huang, Z. P., et al. (2009). MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. Journal of Clinical Investigation, 119, 2772–2786.PubMedCrossRef

13.

Callis, T. E., & Wang, D. Z. (2008). Taking microRNAs to heart. Trends in Molecular Medicine, 14, 254–260.PubMedCrossRef

14.

Care, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., et al. (2007). MicroRNA-133 controls cardiac hypertrophy. Nature Medicine, 13, 613–618.PubMedCrossRef

15.

Chen, J. F., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., et al. (2006). The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nature Genetics, 38, 228–233.PubMedCrossRef

16.

Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., et al. (2008). Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 18, 997–1006.PubMedCrossRef

17.

Cheng, Y., Ji, R., Yue, J., Yang, J., Liu, X., Chen, H., et al. (2007). MicroRNAs are aberrantly expressed in hypertrophic heart: Do they play a role in cardiac hypertrophy? American Journal of Pathology, 170, 1831–1840.PubMedCrossRef

18.

Cheng, Y., Liu, X., Yang, J., Lin, Y., Xu, D. Z., Lu, Q., et al. (2009). MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circulation Research, 105, 158–166.PubMedCrossRef

19.

Chim, S. S., Shing, T. K., Hung, E. C., Leung, T. Y., Lau, T. K., Chiu, R. W., et al. (2008). Detection and characterization of placental microRNAs in maternal plasma. Clinical Chemistry, 54, 482–490.PubMedCrossRef

20.

Clop, A., Marcq, F., Takeda, H., Pirottin, D., Tordoir, X., Bibe, B., et al. (2006). A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nature Genetics, 38, 813–818.PubMedCrossRef

21.

Cordes, K. R., Sheehy, N. T., White, M. P., Berry, E. C., Morton, S. U., Muth, A. N., et al. (2009). miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature, 460, 705–710.PubMed

22.

Cordes, K. R., & Srivastava, D. (2009). MicroRNA regulation of cardiovascular development. Circulation Research, 104, 724–732.PubMedCrossRef

23.

Cortez, M. A., & Calin, G. A. (2009). MicroRNA identification in plasma and serum: A new tool to diagnose and monitor diseases. Expert Opinion on Biol Ther, 9, 703–711.CrossRef

24.

Currie, R. W., Tanguay, R. M., & Kingma, J. G., Jr. (1993). Heat-shock response and limitation of tissue necrosis during occlusion/reperfusion in rabbit hearts. Circulation, 87, 963–971.PubMed

25.

da Costa Martins, P. A., Bourajjaj, M., Gladka, M., Kortland, M., van Oort, R. J., Pinto, Y. M., et al. (2008). Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation, 118, 1567–1576.PubMedCrossRef

26.

Divakaran, V., & Mann, D. L. (2008). The emerging role of microRNAs in cardiac remodeling and heart failure. Circulation Research, 103, 1072–1083.PubMedCrossRef

27.

Dong, S., Cheng, Y., Yang, J., Li, J., Liu, X., Wang, X., et al. (2009). MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. Journal of Biological Chemistry, 284, 29514–29525.PubMedCrossRef

28.

Duisters, R. F., Tijsen, A. J., Schroen, B., Leenders, J. J., Lentink, V., van der Made, I., et al. (2009). miR-133 and miR-30 regulate connective tissue growth factor: Implications for a role of microRNAs in myocardial matrix remodeling. Circ Res, 104, 170–178. 176p following 178.PubMedCrossRef

29.

Ebert, M. S., Neilson, J. R., & Sharp, P. A. (2007). MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells. Nat Methods, 4, 721–726.PubMedCrossRef

30.

Elmen, J., Lindow, M., Schutz, S., Lawrence, M., Petri, A., Obad, S., et al. (2008). LNA-mediated microRNA silencing in non-human primates. Nature, 452, 896–899.PubMedCrossRef

31.

Elmen, J., Lindow, M., Silahtaroglu, A., Bak, M., Christensen, M., Lind-Thomsen, A., et al. (2008). Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Research, 36, 1153–1162.PubMedCrossRef

32.

Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., et al. (2006). miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab, 3, 87–98.PubMedCrossRef

33.

Eulalio, A., Huntzinger, E., & Izaurralde, E. (2008). Getting to the root of miRNA-mediated gene silencing. Cell, 132, 9–14.PubMedCrossRef

34.

Fasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., et al. (2008). MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. Journal of Biological Chemistry, 283, 15878–15883.PubMedCrossRef

35.

Fish, J. E., Santoro, M. M., Morton, S. U., Yu, S., Yeh, R. F., Wythe, J. D., et al. (2008). miR-126 regulates angiogenic signaling and vascular integrity. Developments in Cell, 15, 272–284.CrossRef

36.

Frey, N., & Olson, E. N. (2003). Cardiac hypertrophy: The good, the bad, and the ugly. Annual Review of Physiology, 65, 45–79.PubMedCrossRef

37.

Friedman, R. C., Farh, K. K., Burge, C. B., & Bartel, D. P. (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Research, 19, 92–105.PubMedCrossRef

38.

Gilad, S., Meiri, E., Yogev, Y., Benjamin, S., Lebanony, D., Yerushalmi, N., et al. (2008). Serum microRNAs are promising novel biomarkers. PLoS ONE, 3, e3148.PubMedCrossRef

39.

Griffiths-Jones, S., Saini, H. K., van Dongen, S., & Enright, A. J. (2008). miRBase: Tools for microRNA genomics. Nucleic Acids Research, 36, D154–D158.PubMedCrossRef

40.

Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., et al. (2006). Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature, 441, 537–541.PubMedCrossRef

41.

Hoffman, J. I. (1995). Incidence of congenital heart disease: II. Prenatal incidence. Pediatric Cardiology, 16, 155–165.PubMedCrossRef

42.

Horie, T., Ono, K., Nishi, H., Iwanaga, Y., Nagao, K., Kinoshita, M., et al. (2009). MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes. Biochemical and Biophysical Research Communications, 389, 315–320.PubMedCrossRef

43.

Hunter, J. J., & Chien, K. R. (1999). Signaling pathways for cardiac hypertrophy and failure. New England Journal of Medicine, 341, 1276–1283.PubMedCrossRef

44.

Hunter, M. P., Ismail, N., Zhang, X., Aguda, B. D., Lee, E. J., Yu, L., et al. (2008). Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE, 3, e3694.PubMedCrossRef

45.

Hutter, M. M., Sievers, R. E., Barbosa, V., & Wolfe, C. L. (1994). Heat-shock protein induction in rat hearts. A direct correlation between the amount of heat-shock protein induced and the degree of myocardial protection. Circulation, 89, 355–360.PubMed

46.

Ikeda, S., Kong, S. W., Lu, J., Bisping, E., Zhang, H., Allen, P. D., et al. (2007). Altered microRNA expression in human heart disease. Physiological Genomics, 31, 367–373.PubMedCrossRef

47.

Ivey, K. N., Muth, A., Arnold, J., King, F. W., Yeh, R. F., Fish, J. E., et al. (2008). MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell, 2, 219–229.PubMedCrossRef

48.

Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., et al. (2006). Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing. RNA, 12, 1197–1205.PubMedCrossRef

49.

Ji, R., Cheng, Y., Yue, J., Yang, J., Liu, X., Chen, H., et al. (2007). MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circulation Research, 100, 1579–1588.PubMedCrossRef

50.

Ji, X., Takahashi, R., Hiura, Y., Hirokawa, G., Fukushima, Y., & Iwai, N. (2009). Plasma miR-208 as a biomarker of myocardial injury. Clinical Chemistry, 55, 1944–1949.PubMedCrossRef

51.

Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., et al. (2005). RAS is regulated by the let-7 microRNA family. Cell, 120, 635–647.PubMedCrossRef

52.

Kajstura, J., Urbanek, K., Rota, M., Bearzi, C., Hosoda, T., Bolli, R., et al. (2008). Cardiac stem cells and myocardial disease. Journal of Molecular and Cellular Cardiology, 45, 505–513.PubMedCrossRef

53.

Kim, H. W., Haider, H. K., Jiang, S., & Ashraf, M. (2009). Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8 associated protein 2. Journal of Biological Chemistry, 284, 33161–33168.PubMedCrossRef

54.

Kloosterman, W. P., Wienholds, E., Ketting, R. F., & Plasterk, R. H. (2004). Substrate requirements for let-7 function in the developing zebrafish embryo. Nucleic Acids Research, 32, 6284–6291.PubMedCrossRef

55.

Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., et al. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Medicine, 7, 430–436.PubMedCrossRef

56.

Krutzfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., et al. (2005). Silencing of microRNAs in vivo with ‘antagomirs’. Nature, 438, 685–689.PubMedCrossRef

57.

Kuehbacher, A., Urbich, C., & Dimmeler, S. (2008). Targeting microRNA expression to regulate angiogenesis. Trends in Pharmacological Sciences, 29, 12–15.PubMedCrossRef

58.

Kuehbacher, A., Urbich, C., Zeiher, A. M., & Dimmeler, S. (2007). Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circulation Research, 101, 59–68.PubMedCrossRef

59.

Kwon, C., Han, Z., Olson, E. N., & Srivastava, D. (2005). MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. Proceedings of the National Academy of Sciences of the United States of America, 102, 18986–18991.PubMedCrossRef

60.

Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., & Tuschl, T. (2002). Identification of tissue-specific microRNAs from mouse. Current Biology, 12, 735–739.PubMedCrossRef

61.

Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell, 129, 1401–1414.PubMedCrossRef

62.

Laterza, O. F., Lim, L., Garrett-Engele, P. W., Vlasakova, K., Muniappa, N., Tanaka, W. K., et al. (2009). Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury. Clinical Chemistry, 55, 1977–1983.PubMedCrossRef

63.

Latronico, M. V., Catalucci, D., & Condorelli, G. (2007). Emerging role of microRNAs in cardiovascular biology. Circulation Research, 101, 1225–1236.PubMedCrossRef

64.

Latronico, M. V., & Condorelli, G. (2009). MicroRNAs and cardiac pathology. Nature Reviews Cardiol, 6, 419–429.

65.

Lee, I., Ajay, S. S., Yook, J. I., Kim, H. S., Hong, S. H., Kim, N. H., et al. (2009). New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites. Genome Res, 19, 1175–1183.PubMedCrossRef

66.

Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843–854.PubMedCrossRef

67.

Lee, Y., Kim, M., Han, J., Yeom, K. H., Lee, S., Baek, S. H., et al. (2004). MicroRNA genes are transcribed by RNA polymerase II. EMBO Journal, 23, 4051–4060.PubMedCrossRef

68.

Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15–20.PubMedCrossRef

69.

Liu, J., Valencia-Sanchez, M. A., Hannon, G. J., & Parker, R. (2005). MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nature Cell Biology, 7, 719–723.PubMedCrossRef

70.

Liu, N., Williams, A. H., Kim, Y., McAnally, J., Bezprozvannaya, S., Sutherland, L. B., et al. (2007). An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proceedings of the National Academy of Sciences of the United States of America, 104, 20844–20849.PubMedCrossRef

71.

Liu, X., Cheng, Y., Zhang, S., Lin, Y., Yang, J., & Zhang, C. (2009). A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circulation Research, 104, 476–487.PubMedCrossRef

72.

Loya, C. M., Lu, C. S., Van Vactor, D., & Fulga, T. A. (2009). Transgenic microRNA inhibition with spatiotemporal specificity in intact organisms. Nat Methods, 6, 897–903.PubMedCrossRef

73.

Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., et al. (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834–838.PubMedCrossRef

74.

Lu, Y., Zhang, Y., Shan, H., Pan, Z., Li, X., Li, B., et al. (2009). MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: A new mechanism for ischaemic cardioprotection. Cardiovascular Research, 84, 434–441.PubMedCrossRef

75.

Luo, X., Lin, H., Pan, Z., Xiao, J., Zhang, Y., Lu, Y., et al. (2008). Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. Journal of Biological Chemistry, 283, 20045–20052.PubMedCrossRef

76.

Luo, X., Xiao, J., Lin, H., Li, B., Lu, Y., Yang, B., et al. (2007). Transcriptional activation by stimulating protein 1 and post-transcriptional repression by muscle-specific microRNAs of IKs-encoding genes and potential implications in regional heterogeneity of their expressions. Journal of Cellular Physiology, 212, 358–367.PubMedCrossRef

77.

Lytle, J. R., Yario, T. A., & Steitz, J. A. (2007). Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. Proceedings of the National Academy of Sciences of the United States of America, 104, 9667–9672.PubMedCrossRef

78.

Mandel, E. M., Callis, T. E., Wang, D. Z., & Conlon, F. L. (2005). Transcriptional mechanisms of congenital heart disease. Drug Discovery Today, 2, 33–38.PubMed

79.

Marber, M. S., Latchman, D. S., Walker, J. M., & Yellon, D. M. (1993). Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation, 88, 1264–1272.PubMed

80.

Martinez, J., Patkaniowska, A., Urlaub, H., Luhrmann, R., & Tuschl, T. (2002). Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell, 110, 563–574.PubMedCrossRef

81.

Mathonnet, G., Fabian, M. R., Svitkin, Y. V., Parsyan, A., Huck, L., Murata, T., et al. (2007). MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science, 317, 1764–1767.PubMedCrossRef

82.

Matkovich, S. J., Van Booven, D. J., Youker, K. A., Torre-Amione, G., Diwan, A., Eschenbacher, W. H., et al. (2009). Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation, 119, 1263–1271.PubMedCrossRef

83.

Meng, F., Henson, R., Wehbe-Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133, 647–658.PubMedCrossRef

84.

Menghini, R., Casagrande, V., Cardellini, M., Martelli, E., Terrinoni, A., Amati, F., et al. (2009). MicroRNA-217 modulates endothelial cell senescence via silent information regulator 1. Circulation, 120, 1524–1532.PubMedCrossRef

85.

Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America, 105, 10513–10518.PubMedCrossRef

86.

Naga Prasad, S. V., Duan, Z. H., Gupta, M. K., Surampudi, V. S., Volinia, S., Calin, G. A., et al. (2009). Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. Journal of Biological Chemistry, 284, 27487–27499.PubMedCrossRef

87.

Ng, E. K., Chong, W. W., Jin, H., Lam, E. K., Shin, V. Y., Yu, J., et al. (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening. Gut, 58, 1375–1381.PubMedCrossRef

88.

Petersen, C. P., Bordeleau, M. E., Pelletier, J., & Sharp, P. A. (2006). Short RNAs repress translation after initiation in mammalian cells. Molecular Cell, 21, 533–542.PubMedCrossRef

89.

Pillai, R. S., Bhattacharyya, S. N., Artus, C. G., Zoller, T., Cougot, N., Basyuk, E., et al. (2005). Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science, 309, 1573–1576.PubMedCrossRef

90.

Place, R. F., Li, L. C., Pookot, D., Noonan, E. J., & Dahiya, R. (2008). MicroRNA-373 induces expression of genes with complementary promoter sequences. Proceedings of the National Academy of Sciences of the United States of America, 105, 1608–1613.PubMedCrossRef

91.

Rane, S., He, M., Sayed, D., Vashistha, H., Malhotra, A., Sadoshima, J., et al. (2009). Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circulation Research, 104, 879–886.PubMedCrossRef

92.

Ransom, J., & Srivastava, D. (2007). The genetics of cardiac birth defects. Seminars in Cell & Developmental Biology, 18, 132–139.CrossRef

93.

Rao, P. K., Kumar, R. M., Farkhondeh, M., Baskerville, S., & Lodish, H. F. (2006). Myogenic factors that regulate expression of muscle-specific microRNAs. Proceedings of the National Academy of Sciences of the United States of America, 103, 8721–8726.PubMedCrossRef

94.

Rao, P. K., Toyama, Y., Chiang, H. R., Gupta, S., Bauer, M., Medvid, R., et al. (2009). Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circulation Research, 105, 585–594.PubMedCrossRef

95.

Ren, X. P., Wu, J., Wang, X., Sartor, M. A., Qian, J., Jones, K., et al. (2009). MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation, 119, 2357–2366.PubMedCrossRef

96.

Roy, S., Khanna, S., Hussain, S. R., Biswas, S., Azad, A., Rink, C., et al. (2009). MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovascular Research, 82, 21–29.PubMedCrossRef

97.

Sayed, D., Hong, C., Chen, I. Y., Lypowy, J., & Abdellatif, M. (2007). MicroRNAs play an essential role in the development of cardiac hypertrophy. Circulation Research, 100, 416–424.PubMedCrossRef

98.

Sayed, D., Rane, S., Lypowy, J., He, M., Chen, I. Y., Vashistha, H., et al. (2008). MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Molecular Biology of the Cell, 19, 3272–3282.PubMedCrossRef

99.

Scheinowitz, M., Abramov, D., & Eldar, M. (1997). The role of insulin-like and basic fibroblast growth factors on ischemic and infarcted myocardium: A mini review. International Journal of Cardiology, 59, 1–5.PubMedCrossRef

100.

Schipper, M. E., van Kuik, J., de Jonge, N., Dullens, H. F., & de Weger, R. A. (2008). Changes in regulatory microRNA expression in myocardium of heart failure patients on left ventricular assist device support. Journal of Heart and Lung Transplantation, 27, 1282–1285.PubMedCrossRef

101.

Shan, H., Li, X., Pan, Z., Zhang, L., Cai, B., Zhang, Y., et al. (2009). Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1. British Journal of Pharmacology, 158, 1227–1235.PubMedCrossRef

102.

Shan, Z. X., Lin, Q. X., Fu, Y. H., Deng, C. Y., Zhou, Z. L., Zhu, J. N., et al. (2009). Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Biochemical and Biophysical Research Communications, 381, 597–601.PubMedCrossRef

103.

Shilo, S., Roy, S., Khanna, S., & Sen, C. K. (2008). Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 471–477.PubMedCrossRef

104.

Silvestri, P., Rigattieri, S., & Loschiavo, P. (2008). Does the effect of microRNAs in vascular neointimal formation depend on cell cycle phase? Circulation Research, 102, e101. author reply e102.PubMedCrossRef

105.

Sokol, N. S., & Ambros, V. (2005). Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes and Development, 19, 2343–2354.PubMedCrossRef

106.

Subramanian, S., Lui, W. O., Lee, C. H., Espinosa, I., Nielsen, T. O., Heinrich, M. C., et al. (2008). MicroRNA expression signature of human sarcomas. Oncogene, 27, 2015–2026.PubMedCrossRef

107.

Suckau, L., Fechner, H., Chemaly, E., Krohn, S., Hadri, L., Kockskamper, J., et al. (2009). Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy. Circulation, 119, 1241–1252.PubMedCrossRef

108.

Syed, I. S., Sanborn, T. A., & Rosengart, T. K. (2004). Therapeutic angiogenesis: A biologic bypass. Cardiology, 101, 131–143.PubMedCrossRef

109.

Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., et al. (1999). Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Medicine, 5, 434–438.PubMedCrossRef

110.

Takaya, T., Ono, K., Kawamura, T., Takanabe, R., Kaichi, S., Morimoto, T., et al. (2009). MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells. Circolo J, 73, 1492–1497.CrossRef

111.

Tang, Y., Zheng, J., Sun, Y., Wu, Z., Liu, Z., & Huang, G. (2009). MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Int Heart J, 50, 377–387.PubMedCrossRef

112.

Tatsuguchi, M., Seok, H. Y., Callis, T. E., Thomson, J. M., Chen, J. F., Newman, M., et al. (2007). Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. Journal of Molecular and Cellular Cardiology, 42, 1137–1141.PubMedCrossRef

113.

Taulli, R., Bersani, F., Foglizzo, V., Linari, A., Vigna, E., Ladanyi, M., et al. (2009). The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. Journal of Clinical Investigation, 119, 2366–2378.PubMed

114.

Thum, T., Catalucci, D., & Bauersachs, J. (2008). MicroRNAs: Novel regulators in cardiac development and disease. Cardiovascular Research, 79, 562–570.PubMedCrossRef

115.

Thum, T., Galuppo, P., Wolf, C., Fiedler, J., Kneitz, S., van Laake, L. W., et al. (2007). MicroRNAs in the human heart: A clue to fetal gene reprogramming in heart failure. Circulation, 116, 258–267.PubMedCrossRef

116.

Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., et al. (2008). MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature, 456, 980–984.PubMedCrossRef

117.

Urbich, C., Kuehbacher, A., & Dimmeler, S. (2008). Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovascular Research, 79, 581–588.PubMedCrossRef

118.

Valastyan, S., Reinhardt, F., Benaich, N., Calogrias, D., Szasz, A. M., Wang, Z. C., et al. (2009). A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell, 137, 1032–1046.PubMedCrossRef

119.

van Rooij, E., Quiat, D., Johnson, B. A., Sutherland, L. B., Qi, X., Richardson, J. A., et al. (2009). A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Developments in Cell, 17, 662–673.CrossRef

120.

van Rooij, E., Sutherland, L. B., Liu, N., Williams, A. H., McAnally, J., Gerard, R. D., et al. (2006). A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proceedings of the National Academy of Sciences of the United States of America, 103, 18255–18260.PubMedCrossRef

121.

van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007). Control of stress-dependent cardiac growth and gene expression by a microRNA. Science, 316, 575–579.PubMedCrossRef

122.

van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., et al. (2008). Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proceedings of the National Academy of Sciences of the United States of America, 105, 13027–13032.PubMedCrossRef

123.

van Solingen, C., Seghers, L., Bijkerk, R., Duijs, J. M., Roeten, M. K., van Oeveren-Rietdijk, A. M., et al. (2009). Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. Journal of Cellular and Molecular Medicine, 13, 1577–1585.PubMedCrossRef

124.

Vasilescu, C., Rossi, S., Shimizu, M., Tudor, S., Veronese, A., Ferracin, M., et al. (2009). MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS ONE, 4, e7405.PubMedCrossRef

125.

Vasudevan, S., Tong, Y., & Steitz, J. A. (2007). Switching from repression to activation: MicroRNAs can up-regulate translation. Science, 318, 1931–1934.PubMedCrossRef

126.

Wang, H., Garzon, R., Sun, H., Ladner, K. J., Singh, R., Dahlman, J., et al. (2008). NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell, 14, 369–381.PubMedCrossRef

127.

Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., et al. (2008). The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Developments in Cell, 15, 261–271.CrossRef

128.

Wienholds, E., Koudijs, M. J., van Eeden, F. J., Cuppen, E., & Plasterk, R. H. (2003). The microRNA-producing enzyme Dicer1 is essential for zebrafish development. Nature Genetics, 35, 217–218.PubMedCrossRef

129.

Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., et al. (2007). Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nature Biotechnology, 25, 1149–1157.PubMedCrossRef

130.

Xiao, J., Luo, X., Lin, H., Zhang, Y., Lu, Y., Wang, N., et al. (2007). MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts. Journal of Biological Chemistry, 282, 12363–12367.PubMedCrossRef

131.

Xu, C., Lu, Y., Pan, Z., Chu, W., Luo, X., Lin, H., et al. (2007). The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. Journal of Cell Science, 120, 3045–3052.PubMedCrossRef

132.

Yang, B., Lin, H., Xiao, J., Lu, Y., Luo, X., Li, B., et al. (2007). The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nature Medicine, 13, 486–491.PubMedCrossRef

133.

Yekta, S., Shih, I. H., & Bartel, D. P. (2004). MicroRNA-directed cleavage of HOXB8 mRNA. Science, 304, 594–596.PubMedCrossRef

134.

Yin, C., Salloum, F. N., & Kukreja, R. C. (2009). A novel role of microRNA in late preconditioning: Upregulation of endothelial nitric oxide synthase and heat shock protein 70. Circulation Research, 104, 572–575.PubMedCrossRef

135.

Yin, C., Wang, X., & Kukreja, R. C. (2008). Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice. FEBS Letters, 582, 4137–4142.PubMedCrossRef

136.

York, M., Scudamore, C., Brady, S., Chen, C., Wilson, S., Curtis, M., et al. (2007). Characterization of troponin responses in isoproterenol-induced cardiac injury in the Hanover Wistar rat. Toxicologic Pathology, 35, 606–617.PubMedCrossRef

137.

Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., et al. (2007). Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell, 129, 303–317.PubMedCrossRef

138.

Zhao, Y., Samal, E., & Srivastava, D. (2005). Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature, 436, 214–220.PubMedCrossRef

Titel: MicroRNAs in Cardiovascular Diseases: Biology and Potential Clinical Applications
verfasst von: Reena V. Kartha
Subbaya Subramanian
Publikationsdatum: 01.06.2010
Verlag: Springer US
Erschienen in: Journal of Cardiovascular Translational Research / Ausgabe 3/2010
Print ISSN: 1937-5387
Elektronische ISSN: 1937-5395
DOI: https://doi.org/10.1007/s12265-010-9172-z

Neu im Fachgebiet Kardiologie

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Weniger Extremitätenischämien mit dualer Plättchenhemmung

02.05.2024 Thrombozytenaggregationshemmer Nachrichten

Eine Behandlung mit Ticagrelor zusätzlich zu ASS kann das Risiko für Revaskularisierungen und Amputationen von Extremitäten bei Diabetikern mit stabiler KHK deutlich reduzieren, vor allem für solche mit PAVK. Dafür spricht eine Auswertung der Interventionsstudie THEMIS.

Beutel versus Maschine: Beste Beatmungstechnik bei Herzstillstand gesucht

02.05.2024 Kardiopulmonale Reanimation Nachrichten

Stehen die Chancen auf eine Rückkehr der Spontanzirkulation nach Herz-Kreislauf-Stillstand bei manueller oder maschineller Beatmung besser? Und unterscheidet sich das neurologische Outcome nach der Reanimation? Das belgische Herzstillstand-Register liefert die Daten für einen direkten Vergleich zwischen Beutel und Beatmungsgerät.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

MicroRNAs in Cardiovascular Diseases: Biology and Potential Clinical Applications

Abstract

Neu im Fachgebiet Kardiologie

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

Weniger Extremitätenischämien mit dualer Plättchenhemmung

Beutel versus Maschine: Beste Beatmungstechnik bei Herzstillstand gesucht

Update Kardiologie

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2010

MicroRNAs—Regulators of Signaling Networks in Dilated Cardiomyopathy

Human DNA Methyltransferase 3a does not Associate with MicroRNAs in the Regulation of DNA Methylation

MicroRNA Expression and Function in Cardiac Ischemic Injury

MicroRNAs in Cardiac Apoptosis

miRNAs as Therapeutic Targets in Ischemic Heart Disease

The Genome-Wide Association Study—A New Era for Common Polygenic Disorders

Neu im Fachgebiet Kardiologie

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

Weniger Extremitätenischämien mit dualer Plättchenhemmung

Beutel versus Maschine: Beste Beatmungstechnik bei Herzstillstand gesucht

Update Kardiologie